Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0250
+0.0950 (4.92%)
NASDAQ· Last Trade: Jun 30th, 3:41 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors